FVF2
CARM

Flagship Ventures Fund 2007’s Carisma Therapeutics CARM Stock Holding History

Flagship Ventures Fund 2007’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		$610K Buy
+95,350
New +$1.32M 0.64% 3

Other funds holding CARM

FVFI
Flagship Ventures Fund IV Cambridge, Massachusetts $382M AUM
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Flagship Ventures Fund 2007's CARM Position: Q1 2016 in Review

Flagship Ventures Fund 2007 opened a new position in Carisma Therapeutics (CARM) in Q1 2016: 95,350 shares worth $610K. The stake represents 0.64% of the portfolio and ranks #3 among its holdings.

23 funds tracked by Wall St. Rank hold CARM as of Q1 2016.

  • Flagship Ventures Fund 2007 held 95,350 shares of Carisma Therapeutics worth $610K as of Q1 2016.
  • Carisma Therapeutics was a new Flagship Ventures Fund 2007 position in Q1 2016.
  • Carisma Therapeutics made up 0.64% of Flagship Ventures Fund 2007's portfolio in Q1 2016, its #3 holding.
  • 23 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q1 2016.

Based on Flagship Ventures Fund 2007's 13F filing for Q1 2016, filed 13 May 2016.